Skip to contentSkip to content
What we do
How we work
Current projects
Who we are
News
Publications
What we do
How we work
Current projects
Who we are
News
Publications
News & blog
Keeping you up to date with the latest developments in science, policy and health
S1R1C1
Blog
Further pieces found in the puzzle of severe COVID-19
Friday March 11, 2022
A new study has provided further details on the genetic causes contributing to severe COVID-19.
Blog
Innovative regulation: keeping pace with genomics and software devices
Thursday December 16, 2021
MHRA proposals on software and genetic testing devices are some of the most innovative and exciting developments set out for consultation.
Blog
Host genomics and COVID-19: where are we now?
Monday October 25, 2021
COVID-19 can have severe effects on even apparently low-risk individuals, and it has become clear that host factors affecting the risk of infection and disease progression include genomics.
Blog
COPI notices extended until March 2022
Monday September 27, 2021
The quiet extension by the UK Government of measures for lawful processing of confidential patient information for COVID-19 purposes is likely to have been welcomed by researchers.
Blog
Economies of scale: Genetically-targeted therapies
Wednesday September 15, 2021
The genomics revolution has given us an exceptional understanding of what genes do, how they are expressed (turned on or off), and what happens when they don’t work as they should.
Blog
Long reads
Monday September 6, 2021
Some things are just too interesting to reduce to a few hundred words. The PHG Foundation's long read series takes a deeper dive into areas of new science and their implications for health policy
Blog
What does ‘good governance’ look like for genome editing?
Wednesday July 21, 2021
PHG Policy Analyst, Tanya Brigden, usefully summarises the recommendations for the WHO's considerations towards genome editing
Blog
Expanding the public and patient role in medical regulation
Tuesday July 6, 2021
A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI).
Blog
Making the UK a science superpower – will policy moves pay off for health?
Monday June 28, 2021
The recent and abrupt change in Secretary of State for Health for the UK has overshadowed some very significant policy developments over the last week.
« First
❮
5
6
7
8
9
❯
Last »
S2R1C1